Carvedilol improves liver cirrhosis in rats by inhibiting hepatic stellate cell activation, proliferation, invasion and collagen synthesis

Portal hypertension (PHT) is one of the most severe consequences of liver cirrhosis. Carvedilol is a first-line pharmacological treatment of PHT. However, the antifibrogenic effects of carvedilol on liver cirrhosis and the intrinsic mechanisms underlying these effects have not been thoroughly invest...

Descripción completa

Detalles Bibliográficos
Autores principales: Ling, Liping, Li, Guangqi, Wang, Guangchuan, Meng, Dongxiao, Li, Zhen, Zhang, Chunqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6625452/
https://www.ncbi.nlm.nih.gov/pubmed/31257490
http://dx.doi.org/10.3892/mmr.2019.10401

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6625452/
https://www.ncbi.nlm.nih.gov/pubmed/31257490
http://dx.doi.org/10.3892/mmr.2019.10401

Ejemplares similares